Irene Baccelli
Heidelberg, BW 69120, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Complementary efficacy of CD127-directed immunotherapy with lusvertikimab and ABL-targeting tyrosine kinase inhibitors in preclinical ABL-class-fusion-positive B-ALL.
Journal: HemaSphere
Published: September 09, 2025
CLEC-1 Restrains Acute Inflammatory Response and Recruitment of Neutrophils following Tissue Injury.
CLEC-1 Restrains Acute Inflammatory Response and Recruitment of Neutrophils following Tissue Injury.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: July 17, 2023
CLEC-1 is a death sensor that limits antigen cross-presentation by dendritic cells and represents a target for cancer immunotherapy.
Journal: Science advances
Published: November 18, 2022
First-in-Human Study in Healthy Subjects with the Noncytotoxic Monoclonal Antibody OSE-127, a Strict Antagonist of IL-7Rα.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: August 25, 2022
Vesicular trafficking is a key determinant of the statin response in acute myeloid leukemia.
Journal: Blood advances
Published: August 30, 2021
Mubritinib Targets the Electron Transport Chain Complex I and Reveals the Landscape of OXPHOS Dependency in Acute Myeloid Leukemia.
Journal: Cancer cell
Published: June 30, 2018
Chemogenomic Landscape of RUNX1-mutated AML Reveals Importance of RUNX1 Allele Dosage in Genetics and Glucocorticoid Sensitivity.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: May 01, 2017
A novel approach for the identification of efficient combination therapies in primary human acute myeloid leukemia specimens.
Journal: Blood cancer journal
Published: December 09, 2016
Last Updated: 09/26/2026